Advertisement

Anaphylaxis

  • Daniel LoVerde
    Affiliations
    Division of Pulmonary, Critical Care, Allergy and Immunology, Department of Medicine, Wake Forest University School of Medicine and Wake Forest Baptist Medical Center, Winston-Salem, NC
    Search for articles by this author
  • Onyinye I. Iweala
    Affiliations
    Division of Rheumatology, Allergy, and Immunology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC
    Search for articles by this author
  • Ariana Eginli
    Affiliations
    Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA
    Search for articles by this author
  • Guha Krishnaswamy
    Correspondence
    CORRESPONDENCE TO: Guha Krishnaswamy, MD, FCCP, Wake Baptist Hospital and the Wake Forest University School of Medicine, Department of Medicine, Section on Pulmonary, Critical Care, Allergy and Clinical Immunology, Wake Forest School of Medicine and Wake Baptist Hospital, Medical Center Blvd, Watlington Tower, 2nd Floor, Winston Salem, NC 27157
    Affiliations
    Division of Pulmonary, Critical Care, Allergy and Immunology, Department of Medicine, Wake Forest University School of Medicine and Wake Forest Baptist Medical Center, Winston-Salem, NC

    Division of Allergy and Clinical Immunology, Department of Medicine, W.G. (Bill) Hefner VA Medical Center, Salisbury, NC

    Division of Allergy and Clinical Immunology, Department of Medicine, Kernersville Health Care Center, Kernersville, NC
    Search for articles by this author
Published:August 08, 2017DOI:https://doi.org/10.1016/j.chest.2017.07.033
      Anaphylaxis is a systemic, life-threatening disorder triggered by mediators released by mast cells and basophils activated via allergic (IgE-mediated) or nonallergic (non-IgE-mediated) mechanisms. It is a rapidly evolving, multisystem process involving the integumentary, pulmonary, gastrointestinal, and cardiovascular systems. Anaphylaxis and angioedema are serious disorders that can lead to fatal airway obstruction and culminate in cardiorespiratory arrest, resulting in hypoxemia and/or shock. Often, these disorders can be appropriately managed in an outpatient setting; however, these conditions can be severe enough to warrant evaluation of the patient in the ED and in some cases, hospitalization, and management in an ICU. Reports suggest that underdiagnosis and undertreatment of anaphylaxis are common. Several new syndromes have been described recently including bird-egg, pork-cat, delayed allergy to mammalian meat and a diverse group of mast cell activation disorders. Conditions such as postural orthostatic tachycardia syndrome, carcinoid syndrome, Munchausen stridor, and factitious anaphylaxis can present similarly and need to be included in the differential diagnosis. Anaphylaxis is a clinical diagnosis, but plasma tryptase and urinary histamine levels are often elevated, allowing diagnostic confirmation; however, diagnostic testing should not delay treatment as results may not be immediately available. The sine qua non of treatment is avoidance of any known triggers and epinephrine, which should never be delayed if this disorder is suspected. Secondary treatments include fluids, bronchodilators, antihistamines, and glucocorticoids. Patients with cardiopulmonary arrest or airway or vascular compromise require mechanical ventilation, vasopressors, and other advanced life support in the ICU.

      Key Words

      Abbreviations:

      alpha-gal (alpha-galactose), ECLS (extracorporeal life support), IA (idiopathic anaphylaxis), IO (intraosseous), NSAID (nonsteroidal antiinflammatory drug), PAF (platelet-activating factor), VLM (vastus lateralis muscle)
      To read this article in full you will need to make a payment
      Subscribe to CHEST
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Simons F.E.
        • Ardusso L.R.
        • Bilo M.B.
        • et al.
        International consensus on (ICON) anaphylaxis.
        World Allergy Organ J. 2014; 7: 9
        • LoVerde D.
        • Files D.C.
        • Krishnaswamy G.
        Angioedema.
        Crit Care Med. 2017; 45: 725-735
        • Campbell R.L.
        • Li J.T.
        • Nicklas R.A.
        • et al.
        Emergency department diagnosis and treatment of anaphylaxis: a practice parameter.
        Ann Allergy Asthma Immunol. 2014; 113: 599-608
        • Sclar D.A.
        • Lieberman P.L.
        Anaphylaxis: underdiagnosed, underreported, and undertreated.
        Am J Med. 2014; 127: S1-S5
        • Ghably J.
        • Saleh H.
        • Vyas H.
        • et al.
        Paul Ehrlich's mastzellen: a historical perspective of relevant developments in mast cell biology.
        Methods Mol Biol. 2015; 1220: 3-10
        • Ring J.
        • Brockow K.
        • Behrendt H.
        History and classification of anaphylaxis.
        Novartis Found Symp. 2004; 257: 6-16
        • Simons F.E.
        • Ebisawa M.
        • Sanchez-Borges M.
        • et al.
        2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines.
        World Allergy Organ J. 2015; 8: 32
        • Lieberman P.
        • Nicklas R.A.
        • Randolph C.
        • et al.
        Anaphylaxis–a practice parameter update 2015.
        Ann Allergy Asthma Immunol. 2015; 115: 341-384
        • Ventura M.T.
        • Scichilone N.
        • Gelardi M.
        • et al.
        Management of allergic disease in the elderly: key considerations, recommendations and emerging therapies.
        Expert Rev Clin Immunol. 2015; 11: 1219-1228
        • Muraro A.
        • Roberts G.
        • Worm M.
        • et al.
        Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology.
        Allergy. 2014; 69: 1026-1045
        • Sampson H.A.
        • Munoz-Furlong A.
        • Campbell R.L.
        • et al.
        Second symposium on the definition and management of anaphylaxis: summary report–Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium.
        J Allergy Clin Immunol. 2006; 117: 391-397
        • Lee S.
        • Sadosty A.T.
        • Campbell R.L.
        Update on biphasic anaphylaxis.
        Curr Opin Allergy Clin Immunol. 2016; 16: 346-351
        • Grunau B.E.
        • Li J.
        • Yi T.W.
        • et al.
        Incidence of clinically important biphasic reactions in emergency department patients with allergic reactions or anaphylaxis.
        Ann Emerg Med. 2014; 63: 736-744
        • Zisa G.
        • Riccobono F.
        • Calamari A.M.
        • et al.
        A case of protracted hypotension as unique symptom of a biphasic anaphylaxis to amoxicillin.
        Eur Ann Allergy Clin Immunol. 2009; 41: 60-61
        • Jerschow E.
        • Lin R.Y.
        • Scaperotti M.M.
        • et al.
        Fatal anaphylaxis in the United States, 1999-2010: temporal patterns and demographic associations.
        J Allergy Clin Immunol. 2014; 134: 1318-1328
        • Pumphrey R.S.
        Fatal anaphylaxis in the UK, 1992-2001.
        Novartis Found Symp. 2004; 257: 116-128
        • Pumphrey R.S.
        Lessons for management of anaphylaxis from a study of fatal reactions.
        Clin Exp Allergy. 2000; 30: 1144-1150
        • Altman A.M.
        • Camargo Jr., C.A.
        • Simons F.E.
        • et al.
        Anaphylaxis in America: a national physician survey.
        J Allergy Clin Immunol. 2015; 135: 830-833
        • Lieberman P.
        Epidemiology of anaphylaxis.
        Curr Opin Allergy Clin Immunol. 2008; 8: 316-320
        • Lieberman P.
        • Camargo Jr., C.A.
        • Bohlke K.
        • et al.
        Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group.
        Ann Allergy Asthma Immunol. 2006; 97: 596-602
        • Wood R.A.
        • Camargo Jr., C.A.
        • Lieberman P.
        • et al.
        Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States.
        J Allergy Clin Immunol. 2014; 133: 461-467
        • Yang M.S.
        • Kim J.Y.
        • Kim B.K.
        • et al.
        True rise in anaphylaxis incidence: epidemiologic study based on a national health insurance database.
        Medicine (Baltimore). 2017; 96: e5750
        • Jeppesen A.N.
        • Christiansen C.F.
        • Froslev T.
        • et al.
        Hospitalization rates and prognosis of patients with anaphylactic shock in Denmark from 1995 through 2012.
        J Allergy Clin Immunol. 2016; 137: 1143-1147
        • Ma L.
        • Danoff T.M.
        • Borish L.
        Case fatality and population mortality associated with anaphylaxis in the United States.
        J Allergy Clin Immunol. 2014; 133: 1075-1083
        • Rohacek M.
        • Edenhofer H.
        • Bircher A.
        • et al.
        Biphasic anaphylactic reactions: occurrence and mortality.
        Allergy. 2014; 69: 791-797
        • Gibbison B.
        • Sheikh A.
        • McShane P.
        • et al.
        Anaphylaxis admissions to UK critical care units between 2005 and 2009.
        Anaesthesia. 2012; 67: 833-839
        • Krishnaswamy G.
        • Ajitawi O.
        • Chi D.S.
        The human mast cell: an overview.
        Methods Mol Biol. 2006; 315: 13-34
        • Modena B.D.
        • Dazy K.
        • White A.A.
        Emerging concepts: mast cell involvement in allergic diseases.
        Transl Res. 2016; 174: 98-121
        • Warkentin T.E.
        • Greinacher A.
        Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes.
        Expert Opin Drug Saf. 2009; 8: 129-144
        • Brown S.G.
        • Stone S.F.
        • Fatovich D.M.
        • et al.
        Anaphylaxis: clinical patterns, mediator release, and severity.
        J Allergy Clin Immunol. 2013; 132: 1141-1149
        • Vadas P.
        • Gold M.
        • Perelman B.
        • et al.
        Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis.
        N Engl J Med. 2008; 358: 28-35
        • Brown S.G.
        The pathophysiology of shock in anaphylaxis.
        Immunol Allergy Clin North Am. 2007; 27 (v): 165-175
        • Gouel-Cheron A.
        • Harpan A.
        • Mertes P.M.
        • et al.
        Management of anaphylactic shock in the operating room.
        Presse Med. 2016; 45: 774-783
        • Kelley J.L.
        • Chi D.S.
        • Abou-Auda W.
        • et al.
        The molecular role of mast cells in atherosclerotic cardiovascular disease.
        Mol Med Today. 2000; 6: 304-308
        • Jang D.H.
        • Nelson L.S.
        • Hoffman R.S.
        Methylene blue for distributive shock: a potential new use of an old antidote.
        J Med Toxicol. 2013; 9: 242-249
        • Lyons J.J.
        • Yu X.
        • Hughes J.D.
        • et al.
        Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number.
        Nat Genet. 2016; 48: 1564-1569
        • Iweala O.I.
        • Burks A.W.
        Food allergy: our evolving understanding of its pathogenesis, prevention, and treatment.
        Curr Allergy Asthma Rep. 2016; 16: 37
        • Jarvinen K.M.
        Food-induced anaphylaxis.
        Curr Opin Allergy Clin Immunol. 2011; 11: 255-261
        • Garvey L.H.
        Old, new and hidden causes of perioperative hypersensitivity.
        Curr Pharm Des. 2016; 22: 6814-6824
        • Dona I.
        • Salas M.
        • Perkins J.R.
        • et al.
        Hypersensitivity Reactions to non-steroidal anti-inflammatory drugs.
        Curr Pharm Des. 2016; 22: 6784-6802
      1. Bonamichi-Santos R, Castells M. Diagnoses and management of drug hypersensitivity and anaphylaxis in cancer and chronic inflammatory diseases: reactions to taxanes and monoclonal antibodies [published online ahead of print June 8, 2016]. Clin Rev Allergy Immunol. https://doi.org/10.1007/s12016-016-8556-5.

        • Williams S.J.
        • Gupta S.
        Anaphylaxis to IVIG.
        Arch Immunol Ther Exp (Warsz). 2017; 65: 11-19
        • Alvarez-de Lara M.A.
        • Martin-Malo A.
        Hypersensitivity reactions to synthetic haemodialysis membranes an emerging issue?.
        Nefrologia. 2014; 34: 698-702
        • Wang C.
        • Wong S.
        • Graham D.J.
        Risk of anaphylaxis with intravenous iron products.
        JAMA. 2016; 315: 2232-2233
        • Lee S.Y.
        • Ahn K.
        • Kim J.
        • et al.
        A multicenter retrospective case study of anaphylaxis triggers by age in Korean children.
        Allergy Asthma Immunol Res. 2016; 8: 535-540
        • Miller C.W.
        • Guha B.
        • Krishnaswamy G.
        Exercise-induced anaphylaxis: a serious but preventable disorder.
        Phys Sportsmed. 2008; 36: 87-94
        • Schuch A.
        • Brockow K.
        Mastocytosis and Anaphylaxis.
        Immunol Allergy Clin North Am. 2017; 37: 153-164
        • Pravettoni V.
        • Incorvaia C.
        Diagnosis of exercise-induced anaphylaxis: current insights.
        J Asthma Allergy. 2016; 9: 191-198
        • Commins S.P.
        • Satinover S.M.
        • Hosen J.
        • et al.
        Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose.
        J Allergy Clin Immunol. 2009; 123: 426-433
        • Saleh H.
        • Embry S.
        • Nauli A.
        • et al.
        Anaphylactic reactions to oligosaccharides in red meat: a syndrome in evolution.
        Clin Mol Allergy. 2012; 10: 5
        • Commins S.P.
        • Jerath M.R.
        • Cox K.
        • et al.
        Delayed anaphylaxis to alpha-gal, an oligosaccharide in mammalian meat.
        Allergol Int. 2016; 65: 16-20
        • Platts-Mills T.A.
        • Schuyler A.J.
        • Hoyt A.E.
        • et al.
        Delayed anaphylaxis involving IgE to galactose-alpha-1,3-galactose.
        Curr Allergy Asthma Rep. 2015; 15: 12
        • Sabbah A.
        • Lauret M.G.
        • Chene J.
        • et al.
        [The pork-cat syndrome or crossed allergy between pork meat and cat epithelia (2)].
        Allerg Immunol (Paris). 1994; 26: 173-180
        • Hemmer W.
        • Klug C.
        • Swoboda I.
        Update on the bird-egg syndrome and genuine poultry meat allergy.
        Allergo J Int. 2016; 25: 68-75
        • Hedlund K.D.
        • Coyne D.P.
        • Sanford D.M.
        • et al.
        The heparin recall of 2008.
        Perfusion. 2013; 28: 61-65
        • Kishimoto T.K.
        • Viswanathan K.
        • Ganguly T.
        • et al.
        Contaminated heparin associated with adverse clinical events and activation of the contact system.
        N Engl J Med. 2008; 358: 2457-2467
        • Fenny N.
        • Grammer L.C.
        Idiopathic anaphylaxis.
        Immunol Allergy Clin North Am. 2015; 35: 349-362
        • Greenberger P.A.
        • Lieberman P.
        Idiopathic anaphylaxis.
        J Allergy Clin Immunol. Pract. 2014; 2: 243-250
        • Kuhlen J.L.
        • Virkud Y.V.
        Pathogenesis, newly recognized etiologies, and management of idiopathic anaphylaxis.
        Discov Med. 2015; 19: 137-144
        • Akin C.
        Mast cell activation syndromes presenting as anaphylaxis.
        Immunol Allergy Clin North Am. 2015; 35: 277-285
        • Bonadonna P.
        • Bonifacio M.
        • Lombardo C.
        • et al.
        Hymenoptera allergy and mast cell activation syndromes.
        Curr Allergy Asthma Rep. 2016; 16: 5
        • Snyder J.L.
        • Krishnaswamy G.
        Autoimmune progesterone dermatitis and its manifestation as anaphylaxis: a case report and literature review.
        Ann Allergy Asthma Immunol. 2003; 90: 469-477
        • Bauer C.S.
        • Kampitak T.
        • Messieh M.L.
        • et al.
        Heterogeneity in presentation and treatment of catamenial anaphylaxis.
        Ann Allergy Asthma Immunol. 2013; 111: 107-111
        • Lee J.
        • Kim S.
        • Kim M.
        • et al.
        Anaphylaxis to husband's seminal plasma and treatment by local desensitization.
        Clin Mol Allergy. 2008; 6: 13
        • Friedman S.A.
        • Bernstein I.L.
        • Enrione M.
        • et al.
        Successful long-term immunotherapy for human seminal plasma anaphylaxis.
        JAMA. 1984; 251: 2684-2687
        • Burks A.W.
        • Jones S.M.
        • Boyce J.A.
        • et al.
        NIAID-sponsored 2010 guidelines for managing food allergy: applications in the pediatric population.
        Pediatrics. 2011; 128: 955-965
        • Zogaj D.
        • Ibranji A.
        • Hoxha M.
        Exercise-induced anaphylaxis: the role of cofactors.
        Mater Sociomed. 2014; 26: 401-404
        • Druey K.M.
        • Parikh S.M.
        Idiopathic systemic capillary leak syndrome (Clarkson disease).
        J Allergy Clin Immunol. 2016; 140: 663-670
        • Feng C.
        • Teuber S.
        • Gershwin M.E.
        Histamine (scombroid) fish poisoning: a comprehensive review.
        Clin Rev Allergy Immunol. 2016; 50: 64-69
        • Choy A.C.
        • Patterson R.
        • Patterson D.R.
        • et al.
        Undifferentiated somatoform idiopathic anaphylaxis: nonorganic symptoms mimicking idiopathic anaphylaxis.
        J Allergy Clin Immunol. 1995; 96: 893-900
        • Bahna S.L.
        • Oldham J.L.
        Munchausen stridor-a strong false alarm of anaphylaxis.
        Allergy Asthma Immunol Res. 2014; 6: 577-579
        • Waterfield T.
        • Dyer E.
        • Wilson K.
        • et al.
        How to interpret mast cell tests.
        Arch Dis Child Educ Pract Ed. 2016; 101: 246-251
        • Vitte J.
        Human mast cell tryptase in biology and medicine.
        Mol Immunol. 2015; 63: 18-24
        • Simons F.E.
        • Ardusso L.R.
        • Bilo M.B.
        • et al.
        World allergy organization guidelines for the assessment and management of anaphylaxis.
        World Allergy Organ J. 2011; 4: 13-37
        • Tsai G.
        • Kim L.
        • Nevis I.F.
        • et al.
        Auto-injector needle length may be inadequate to deliver epinephrine intramuscularly in women with confirmed food allergy.
        Allergy Asthma Clin Immunol. 2014; 10: 39
        • Pumphrey R.S.
        Fatal posture in anaphylactic shock.
        J Allergy Clin Immunol. 2003; 112: 451-452
        • Commins S.P.
        Outpatient emergencies: anaphylaxis.
        Med Clin North Am. 2017; 101: 521-536
        • Brown S.G.
        Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis.
        Curr Opin Allergy Clin Immunol. 2005; 5: 359-364
        • Zilberstein J.
        • McCurdy M.T.
        • Winters M.E.
        Anaphylaxis.
        J Emerg Med. 2014; 47: 182-187
        • Thomas M.
        • Crawford I.
        Best evidence topic report. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers.
        Emerg Med J. 2005; 22: 272-273
        • Sicherer S.H.
        • Simons F.E.R.
        • Section on Allergy and Immunology
        Epinephrine for first-aid management of anaphylaxis.
        Pediatrics. 2017; 139: e1-e9
        • Zheng F.
        • Barthel G.
        • Collange O.
        • et al.
        Methylene blue and epinephrine: a synergetic association for anaphylactic shock treatment.
        Crit Care Med. 2013; 41: 195-204
        • Chan-Dominy A.C.
        • Anders M.
        • Millar J.
        • et al.
        Extracorporeal membrane modality conversions.
        Perfusion. 2015; 0: 291-294
      Advertisement